Gossamer Bio Derivative Contract Liabilities (Quarterly) Insights

Gossamer Bio, Inc. (GOSS)

0.3629 -0.05 (-12.64%) USD | NASDAQ | Feb 25, 14:21

View Derivative Contract Liabilities (Quarterly) for GOSS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Derivative Contract Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Derivative Contract Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Derivative Contract Liabilities (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
XOMA Royalty Corp.	--
Rezolute, Inc.	Upgrade
Axsome Therapeutics, Inc.	--
Crinetics Pharmaceuticals, Inc.	--